Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birte Jessen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Psychosomatic Research|December 27, 2025
Does symptom perception after negative affect induction differ between physically ill and healthy individuals? An experimental study within SOMA.CKBirte Jessen, Christian Schmidt-Lauber, Tobias B Huber, et al.
Kidney360|January 30, 2026
Biopsychosocial Correlates of Somatic Symptom Burden in CKD: Results of the Hamburg City Health Study (HCHS)Birte Jessen, Bernd Löwe, Raphael Twerenbold, et al.
BMJ Open|November 17, 2022
Predictors of somatic symptom persistence in patients with chronic kidney disease (SOMA.CK): study protocol for a mixed-methods cohort studyMeike C Shedden-Mora, Birte Jessen, Christian Schmidt-Lauber, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancersThorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Psychosomatic Research|December 27, 2025
Does symptom perception after negative affect induction differ between physically ill and healthy individuals? An experimental study within SOMA.CKBirte Jessen, Christian Schmidt-Lauber, Tobias B Huber, et al.
Kidney360|January 30, 2026
Biopsychosocial Correlates of Somatic Symptom Burden in CKD: Results of the Hamburg City Health Study (HCHS)Birte Jessen, Bernd Löwe, Raphael Twerenbold, et al.
BMJ Open|November 17, 2022
Predictors of somatic symptom persistence in patients with chronic kidney disease (SOMA.CK): study protocol for a mixed-methods cohort studyMeike C Shedden-Mora, Birte Jessen, Christian Schmidt-Lauber, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancersThorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancerSarah Minner, Birte Jessen, Lars Stiedenroth, et al.
Pageof 1